COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem
Ann Hepatol. 2021 Sep-Oct;24:100525. doi: 10.1016/j.aohep.2021.100525.NO ABSTRACTPMID:34509271 | PMC:PMC8425075 | DOI:10.1016/j.aohep.2021.100525
Source: Annals of Hepatology - Category: Gastroenterology Authors: Pathum Sookaromdee Viroj Wiwanitkit Source Type: research
More News: COVID-19 | Gastroenterology | Jaundice | Liver | Thrombocytopenia | Urology & Nephrology | Vaccines